[HTML][HTML] Effect of SARS-CoV-2 infection on HBV-infected patients: Reactivation

LAIK Al-Kaif, MAK Al-Saadi… - Medical Journal of …, 2022 - journals.lww.com
Background: Hepatic manifestations of COVID-19 are prevalent in individuals infected with
viral hepatitis type B (HBV). Objectives: The current study aims to determine the extent of the …

[PDF][PDF] Frequency distribution of hepatitis B virus (HBV) genotypes in Iraqi patients

LAIK Al-Kaif, AH Al-Charrakh… - International journal of …, 2022 - researchgate.net
Infection with the hepatitis B virus can lead to asymptomatic carrier status, developing into
severe chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Ten genotypes (AJ) and …

Ethical considerations of the genetic testing for patients with cardiovascular disease

MA Akkaif, NAA Daud - Malaysian Journal of Human Genetics, 2022 - mjhg.kk.usm.my
Findings of genetic markers for cardiovascular diseases (CVDs) have aided in the
development of genetic tests and drug discovery and development strategies. Studies on …

Covid-19, history and modern laboratory diagnostic techniques: A rapid review

MH Jebur, JA Hamawandi, HH Al-Hasnawy… - Journal of …, 2022 - pnrjournal.com
The great catastrophe that the world faced after World War II, which is the Corona epidemic,
was discovered in the 2019 year in Hubei Province, Wuhan, China, and it is a severe …

[HTML][HTML] Immunological Study of Orthodontically Treated Patients Recovering from COVID-19 in Babylon Province, Iraq

BAK Eidan, TJ Al-Khafaji, AM Abbas - Medical Journal of Babylon, 2023 - journals.lww.com
Materials and Methods: Sixty serum and saliva samples were collected and divided into
three groups of 20 patients: patients with COVID-19 who did not receive orthodontic …

Assessment of Pentraxin 3 and Some Biomarker in Patients with Nonalcoholic Fatty Liver Diseases.

MS Abass, G Ghanim… - Hammurabi Journal of …, 2024 - hjms.uobabylon.edu.iq
Background: Globally, one of the most frequent causes of chronic liver disease is non-
alcoholic fatty liver disease (NAFLD). About 30% of the general population suffers from …

Regulatory T Cells and Type 1 Regulatory T Cells as Immuno-Cell Therapy in Type 1 Diabetes

M Sameir, N Soleimanifar, NA Selman… - … Journal of Medical …, 2024 - hjms.uobabylon.edu.iq
Type 1 diabetes is caused by the immune system attacking and destroying pancreatic cells,
leading to a complete lack of insulin throughout the rest of a person's life. For about 100 …